Astrana Health, Inc. (NASDAQ:ASTH) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of Astrana Health, Inc. (NASDAQ:ASTH) have received an average rating of “Moderate Buy” from the eight analysts that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and five have issued a buy recommendation on the company. The average 1-year price target among brokers that have covered the stock in the last year is $34.00.

Several brokerages recently commented on ASTH. BTIG Research reduced their target price on Astrana Health from $45.00 to $40.00 and set a “buy” rating on the stock in a report on Monday, February 2nd. Barclays dropped their price target on shares of Astrana Health from $36.00 to $26.00 and set an “equal weight” rating on the stock in a research report on Monday, November 24th. Needham & Company LLC started coverage on shares of Astrana Health in a research report on Friday, December 12th. They set a “buy” rating and a $28.00 price objective for the company. Truist Financial lifted their target price on shares of Astrana Health from $37.00 to $38.00 and gave the stock a “buy” rating in a research note on Friday, March 13th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Astrana Health in a research report on Monday, December 29th.

Hedge Funds Weigh In On Astrana Health

Institutional investors have recently added to or reduced their stakes in the business. Signaturefd LLC grew its position in shares of Astrana Health by 57.9% during the 4th quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock worth $26,000 after buying an additional 388 shares during the period. GAMMA Investing LLC boosted its stake in Astrana Health by 144.7% during the fourth quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock worth $37,000 after acquiring an additional 871 shares in the last quarter. Strs Ohio bought a new position in Astrana Health during the fourth quarter worth $40,000. Covestor Ltd grew its holdings in Astrana Health by 210.6% in the third quarter. Covestor Ltd now owns 3,233 shares of the company’s stock worth $92,000 after purchasing an additional 2,192 shares during the period. Finally, Tower Research Capital LLC TRC grew its holdings in Astrana Health by 323.3% in the second quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock worth $115,000 after purchasing an additional 3,517 shares during the period. 52.77% of the stock is owned by institutional investors and hedge funds.

Astrana Health Stock Up 0.2%

Shares of NASDAQ:ASTH opened at $24.23 on Friday. The firm has a market cap of $1.35 billion, a P/E ratio of 52.68 and a beta of 0.91. Astrana Health has a 12-month low of $18.08 and a 12-month high of $34.80. The business has a fifty day simple moving average of $23.10 and a 200 day simple moving average of $25.71. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 1.25.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings results on Monday, March 2nd. The company reported $0.54 EPS for the quarter, beating analysts’ consensus estimates of $0.15 by $0.39. Astrana Health had a return on equity of 5.59% and a net margin of 0.71%.The firm had revenue of $950.53 million for the quarter, compared to analyst estimates of $930.46 million. During the same quarter in the previous year, the company posted ($0.15) EPS. The business’s revenue was up 42.9% on a year-over-year basis. Analysts predict that Astrana Health will post 1.15 earnings per share for the current year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.